Use of the experience sampling method in the context of clinical trials

Simone J W Verhagen, Laila Hasmi, Marjan Drukker, J van Os, Philippe A E G Delespaul, Simone J W Verhagen, Laila Hasmi, Marjan Drukker, J van Os, Philippe A E G Delespaul

Abstract

Objective: The experience sampling method (ESM) is a structured diary technique to appraise subjective experiences in daily life. It is applied in psychiatric patients, as well as in patients with somatic illness. Despite the potential of ESM assessment, the improved logistics and its increased administration in research, its use in clinical trials remains limited. This paper introduces ESM for clinical trials in psychiatry and beyond.

Methods: ESM is an ecologically valid method that yields a comprehensive view of an individual's daily life. It allows the assessment of various constructs (eg, quality of life, psychopathology) and psychological mechanisms (eg, stress-sensitivity, coping). These constructs are difficult to assess using cross-sectional questionnaires. ESM can be applied in treatment monitoring, as an ecological momentary intervention, in clinical trials, or in single case clinical trials. Technological advances (eg, smartphone applications) make its implementation easier.

Results: Advantages of ESM are highlighted and disadvantages are discussed. Furthermore, the ecological nature of ESM data and its consequences are explored, including the potential pitfalls of ambiguously formulated research questions and the specificities of ESM in statistical analyses. The last section focuses on ESM in relation to clinical trials and discusses its future use in optimising clinical decision-making.

Conclusions: ESM can be a valuable asset in clinical trial research and should be used more often to study the benefits of treatment in psychiatry and somatic health.

Keywords: PSYCHIATRY; PUBLIC HEALTH.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

References

    1. FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist, 2009:65132–3.
    1. DeVries MW. The experience of psychopathology: investigating mental disorders in their natural settings. New York, NY: Cambridge University Press, 1992.
    1. Palmier-Claus JE, Myin-Germeys I, Barkus E, et al. . Experience sampling research in individuals with mental illness: reflections and guidance. Acta Psychiatr Scand 2011;123:12–20. 10.1111/j.1600-0447.2010.01596.x
    1. Delespaul PAEG. Assessing schizophrenia in daily life the experience sampling method. UPM, Universitaire Pers Maastricht, University Library, Maastricht University [Host], 1995.
    1. Hektner JM, Schmidt JA, Csikszentmihalyi M. Experience sampling method: measuring the quality of everyday life. Thousand Oaks, CA: Sage Publications, 2007.
    1. Stone AA, Shiffman S. Ecological momentary assessment (EMA) in behavorial medicine. Ann Behav Med 1994;16:199–202.
    1. Fahrenberg J, Myrtek M, Pawlik K, et al. . Ambulatory assessment-monitoring behavior in daily life settings. Eur J Psychol Assess 2007;23:206–13. 10.1027/1015-5759.23.4.206
    1. Reis HT, Gable SL. Event-sampling and other methods for studying everyday experience. In: Reis HT, Judd CM. Handbook of research methods in social and personality psychology. New York, NY: Cambridge University Press, 2000:190–222.
    1. Hurlburt R, Heavey CL. To beep or not to beep: obtaining accurate reports about awareness. J Conscious Stud 2004;11:113–28.
    1. Bolger N, Davis A, Rafaeli E. Diary methods: capturing life as it is lived. Annu Rev Psychol 2003;54:579–616. 10.1146/annurev.psych.54.101601.145030
    1. Bolger N, Laurenceau J-P. Intensive longitudinal methods: an introduction to diary and experience sampling research. New York, NY: Guilford Press, 2013.
    1. Stone A, Shiffman S, Atienza A, et al. . The science of real-time data capture: self-reports in health research. New York, NY: Oxford University Press, 2007.
    1. Csikszentmihalyi M, Mehl MR, Conner TS. Handbook of research methods for studying daily life. New York, NY: Guilford Publications, 2013.
    1. Doherty ST, Lemieux CJ, Canally C. Tracking human activity and well-being in natural environments using wearable sensors and experience sampling. Soc Sci Med 2014;106:83–92. 10.1016/j.socscimed.2014.01.048
    1. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol 2008;4:1–32. 10.1146/annurev.clinpsy.3.022806.091415
    1. Myin-Germeys I, Oorschot M, Collip D, et al. . Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med 2009;39:1533–47. 10.1017/S0033291708004947
    1. Simons CJ, Hartmann JA, Kramer I, et al. . Effects of momentary self-monitoring on empowerment in a randomized controlled trial in patients with depression. Eur Psychiatry 2015;30:900–6. 10.1016/j.eurpsy.2015.09.004
    1. Johnson EI, Grondin O, Barrault M, et al. . Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study of acceptability, compliance, and reactivity. Int J Methods Psychiatr Res 2009;18:48–57. 10.1002/mpr.276
    1. Silvia PJ, Kwapil TR, Eddington KM, et al. . Missed beeps and missing data: dispositional and situational predictors of nonresponse in experience sampling research. Soc Sci Comput Rev 2013;8:471–81. 10.1177/0894439313479902
    1. Snijders TA. Multilevel analysis. Berlin Heidelberg: Springer, 2011.
    1. Kimhy D, Myin-Germeys I, Palmier-Claus J, et al. . Mobile assessment guide for research in schizophrenia and severe mental disorders. Schizophr Bull 2012;38:386–95. 10.1093/schbul/sbr186
    1. Larson R, Delespaul P, deVries M. Analyzing experience sampling data: a guidebook for the perplexed. In: DeVries MW. The experience of psychopathology: investigating mental disorders in their natural settings. New York, NY: Cambridge University Press, 1992:58–78.
    1. Wang LP, Maxwell SE. On disaggregating between-person and within-person effects with longitudinal data using multilevel models. Psychol Methods 2015;20:63 10.1037/met0000030
    1. Davison AC, Hinkley DV. Bootstrap methods and their application. New York, NY: Cambridge University Press, 1997.
    1. van Os J, Rutten BP, Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 2008;34:1066–82. 10.1093/schbul/sbn117
    1. DeVries MW. Recontextualizing psychiatry: toward ecologically valid mental health research. Transcult Psychiatry 1997;34:185–218. 10.1177/136346159703400202
    1. Mitchell V, Mathis MD. FDA briefing document; psychopharmacologic drugs advisory committee meeting; topic: cognitive dysfunction in major depressive disorder. In: administration FaD , ed. FDA, 2016:25.
    1. Kramer I, Simons CJ, Hartmann JA, et al. . A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry 2014;13:68–77. 10.1002/wps.20090
    1. Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol 2010;15:1–39. 10.1348/135910709X466063
    1. Davidson KW, Peacock J, Kronish Intramuscular, et al. . Personalizing Behavioral Interventions Through Single-Patient (N-of-1) Trials. Soc Personality Psychol Compass 2014;8:408–21. 10.1111/spc3.12121
    1. Dallery J, Raiff BR. Optimizing behavioral health interventions with single-case designs: from development to dissemination. Transl Behav Med 2014;4:290–303. 10.1007/s13142-014-0258-z
    1. Heyvaert M, Onghena P. Randomization tests for single-case experiments: state of the art, state of the science, and state of the application. J Contextual Behav Sci 2014;3:51–64. 10.1016/j.jcbs.2013.10.002
    1. Bulté I, Onghena P. An R package for single-case randomization tests. Behav Res Methods 2008;40:467–78. 10.3758/BRM.40.2.467
    1. Wichers M, Groot PC, Psychosystems E, et al. . Critical slowing down as a personalized early warning signal for depression. Psychother Psychosom 2016;85:114–16. 10.1159/000441458
    1. Gravenhorst F, Muaremi A, Bardram J, et al. . Mobile phones as medical devices in mental disorder treatment: an overview. Pers Ubiquitous Comput 2015;19:335–53. 10.1007/s00779-014-0829-5
    1. Vilardaga R, Bricker J, McDonell M. The promise of mobile technologies and single case designs for the study of individuals in their natural environment. J Contextual Behav Sci 2014;3:148–53. 10.1016/j.jcbs.2014.03.003

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다